Titan Pharmaceuticals, Inc. (NASDAQ:TTNP)
Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) represented a move of -6.15 percent or $0.02 per share and closed its previous day trading session at $0.31. 3.78 Million Shares were traded in the last trading session with an Average Volume of 9.72 Million Shares. The stock currently has a Market Capitalization of 24.8 Million.
Titan Pharmaceuticals, Inc. is a biopharmaceutical company developing proprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical testing for schizophrenia through a licensing and development agreement with Novartis Pharma AG. Novartis has tradenamed the product Zomaril.
The stock traded between $0.170 and $1.600 over 1-Year time period showing its price to sales ratio of 4.59. Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-3.03 and 200-Day Simple Moving Average of $-59.03. Its Price to Free Cash Flow is 0 and Price to Book of 1.24.
Analyst’s recommended the stock as 2 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) reported its Actual EPS of $-0.11/share. The analysts offering Earnings Estimates for the company were believing that Titan Pharmaceuticals, Inc. could bring EPS of $-0.14/share. The difference between Actual EPS and Estimated EPS was 0.03 Percent. Thus showing an Earnings Surprise of 21.4 Percent.
First Data Corporation (NYSE:FDC)
In the last trading session, First Data Corporation (NYSE:FDC) added its value by 1.05% closing at the price of $19.28. The stock currently has market capitalization of 17.95 Billion, with average volume of 10.02 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently First Data Corporation (NYSE:FDC) is showing beta of 0. This particular value of beta suggests that First Data Corporation (NYSE:FDC) has historically moved 0% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for First Data Corporation (NYSE:FDC) is at $1.51.
The stock currently has RSI of 51.34. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
First Data Corporation is a commerce-enabling technology and solutions company. It provides merchant transaction processing and acquiring; credit, retail and debit card issuing and processing; prepaid services and check verification, settlement and guarantee services. First Data Corporation is headquartered in Atlanta, Georgia.
First Data Corporation (NYSE:FDC) topped its 52-week high price of $26.62 on 09/17/18 and 52-Week Low Price of $14.73 on 04/25/18. The Stock currently has P/E (price to earnings ttm) of 12.78 and Weekly volatility of 3.58% and monthly volatility of 3.75% respectively.